Nyxoah Sa (NYXH)

Jan 06, 2025

Retail investors are Nyxoah S.A.'s (EBR:NYXH) biggest owners and were rewarded after market cap rose by €38m last week - Simply Wall St

Jan 06, 2025

Jan 04, 2025

Nyxoah (NASDAQ:NYXH) Stock Price Up 1.2% – Here’s What Happened - Defense World

Jan 04, 2025

Jan 02, 2025

Nyxoah Receives Transparency Notification from BlackRock, Inc. - TipRanks

Jan 02, 2025

Dec 30, 2024

Nyxoah: The Future Of OSA (NASDAQ:NYXH) - Seeking Alpha

Dec 30, 2024

Dec 29, 2024

How the (NYXH) price action is used to our Advantage - Stock Traders Daily

Dec 29, 2024

Dec 20, 2024

Publication relating to transparency notifications - GlobeNewswire

Dec 20, 2024

Dec 20, 2024

BlackRock Takes 3% Stake in Medical Device Maker Nyxoah in Strategic Investment Move - StockTitan

Dec 20, 2024

Dec 19, 2024

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 - Finansavisen

Dec 19, 2024

Dec 19, 2024

(NYXH) Investment Analysis and Advice - Stock Traders Daily

Dec 19, 2024

Dec 18, 2024

Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles - Investing.com

Dec 18, 2024

Dec 18, 2024

Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles By Investing.com - Investing.com UK

Dec 18, 2024

Dec 15, 2024

Nyxoah's nerve stimulation device meets endpoints in sleep apnoea studyMedical Device Network - Oficjalny Portal Gminy Brzesko

Dec 15, 2024

Dec 15, 2024

HC Wainwright Reaffirms “Buy” Rating for Nyxoah (NASDAQ:NYXH) - Defense World

Dec 15, 2024

Dec 13, 2024

Nyxoah’s Genio Neurostimulator for OSA Launches in England - Sleep Review

Dec 13, 2024

Dec 13, 2024

Nyxoah's SWOT analysis: sleep apnea innovator's stock poised for US launch - Investing.com

Dec 13, 2024

Dec 13, 2024

Nyxoah Launches Revolutionary Sleep Apnea Treatment in England with First NHS-Covered Implants - StockTitan

Dec 13, 2024

Dec 13, 2024

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewswire

Dec 13, 2024

Dec 13, 2024

Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England - Marketscreener.com

Dec 13, 2024

Dec 08, 2024

Where are the Opportunities in (NYXH) - Stock Traders Daily

Dec 08, 2024

Dec 02, 2024

Nyxoah Updates Share Capital and Voting Rights - TipRanks

Dec 02, 2024

Nov 27, 2024

Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire

Nov 27, 2024

Nov 27, 2024

Information on the total number of voting rights and shares - GlobeNewswire

Nov 27, 2024

Nov 27, 2024

Objective long/short (NYXH) Report - Stock Traders Daily

Nov 27, 2024

Nov 27, 2024

Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World

Nov 27, 2024

Nov 21, 2024

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Korea Bizwire

Nov 21, 2024

Nov 20, 2024

Nyxoah to Present at Healthcare Conference Amidst Growth - TipRanks

Nov 20, 2024

Nov 20, 2024

Nyxoah to Present Sleep Apnea Innovation at Piper Sandler Healthcare Conference | NYXH Stock News - StockTitan

Nov 20, 2024

Nov 20, 2024

Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 20, 2024

Nov 19, 2024

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024: Nyxoah - The Korea Bizwire

Nov 19, 2024

Nov 19, 2024

Nyxoah Schedules Special Meeting to Vote on EIB Loan Agreement Terms | NYXH Stock News - StockTitan

Nov 19, 2024

Nov 18, 2024

Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire

Nov 18, 2024

Nov 18, 2024

Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks

Nov 18, 2024

Nov 18, 2024

ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan

Nov 18, 2024

Nov 18, 2024

Publication relating to transparency notifications, Business Wires News - AsiaOne

Nov 18, 2024

Nov 16, 2024

Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat

Nov 16, 2024

Nov 13, 2024

Nyxoah's SWOT analysis: sleep apnea device maker's stock poised for growth - Investing.com India

Nov 13, 2024

Nov 10, 2024

Nyxoah Third Quarter 2024 Earnings: €0.50 loss per share (vs €0.27 loss in 3Q 2023) - Simply Wall St

Nov 10, 2024

Nov 07, 2024

Nyxoah Reports Third Quarter Financial and Operating Results - Wahanariau

Nov 07, 2024

Nov 07, 2024

Nyxoah sales jump 30% to €1.3 million in Q3 2024 - Medical Buyer

Nov 07, 2024

Nov 07, 2024

Nyxoah SA Reports Growth Amid Clinical Advances - TipRanks

Nov 07, 2024

Nov 06, 2024

EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results - sharewise

Nov 06, 2024

Nov 06, 2024

Nyxoah Eyes Strong US Launch Amid Financial Growth - TipRanks

Nov 06, 2024

Nov 06, 2024

Nyxoah S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024

Nov 06, 2024

Nyxoah Reports Third Quarter Financial and Operating Results, Business Wires News - AsiaOne

Nov 06, 2024

Nov 06, 2024

(NYXH) Investment Report - Stock Traders Daily

Nov 06, 2024

Nov 06, 2024

Nyxoah Q3 Revenue Surges 30% as FDA Approval Timeline Stays on Track for 2025 - StockTitan

Nov 06, 2024

Nov 05, 2024

Nyxoah SA (NYXH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Nov 05, 2024

Nov 04, 2024

Nyxoah SA Announces CFO Changes - Marketscreener.com

Nov 04, 2024

Nov 04, 2024

Nyxoah participates in a conference call with Cantor Fitzgerald - TipRanks

Nov 04, 2024

Nov 04, 2024

Nyxoah Appoints John Landry as Chief Financial Officer - The Manila Times

Nov 04, 2024

Oct 31, 2024

Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - MSN

Oct 31, 2024